Skip to main content

Ipamorelin GHRP Therapy

Meaning

Ipamorelin GHRP Therapy is a specific clinical intervention involving the administration of Ipamorelin, a selective Growth Hormone Releasing Peptide (GHRP), to stimulate the pituitary gland’s natural, pulsatile secretion of endogenous Growth Hormone (GH). This therapeutic approach is distinct from administering synthetic GH directly, as it aims to restore a more physiological release pattern, often utilized to address symptoms associated with age-related GH decline, such as reduced muscle mass, decreased bone density, and impaired body composition. The therapy is precisely dosed to maximize GH release while minimizing the potential for side effects.